Overall verdict
Buy
7.3/10
1-year performance
-10.91%
Score breakdown
Down 10.9% over 1 year, 11% of the 52-week range.
Strongest: Valuation 10.0/10. Weakest: Shareholder return 5.5/10.
16 analysts, target +0.5% vs the price.
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. The company operates through Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses segments. It offers life, annuity, health, and accident insurance products to individuals and groups. The company was founded in 1949 and is based in Beijing, the People's Republic of China. China Life Insurance Company Limited operates as a subsidiary of China Life Insurance (Group) Company.
Sector
Financials
Industry
Insurance
Primary listing
Hkex
China
CEO
Mingguang Li
Founded
1949
Employees
97 505
Revenue / employee
5.6M CNY
Next earnings
March 25, 2027 (estimated)
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
36.16 HKD
52-week low
22.24 HKD
1-year performance
-10.91%
Declining
Year-to-date performance
-12.80%
Declining
Drawdown
-34.07%
Major drawdown
Position in the 52-week range
11% of range
Quality and profitability
10.0/10Gross margin 38.8%, net margin 41.3%, ROE 41.3%.
Net margin
41.31%
Exceptional
Sector 6.32%|S&P 13.40%
Gross margin
38.84%
Low
Return on equity (ROE)
41.33%
Exceptional
Sector 12.16%|S&P 17.06%
Return on invested capital (ROIC)
39.00%
Free cash flow margin (FCF)
87.60%
Profit-to-cash conversion (FCF conversion)
2.12x
Margin stability
12.6 pts
Very uneven
Revenue to net income
Growth
7.1/10Revenue up 11.9% over 1 year, -8.0% a year over 5, EPS 24.2% a year over 5.
Revenue (trailing 12 months)
614Md CNY
Revenue growth (1y)
11.91%
Hyper-growth
Revenue growth (3y)
27.37%
Solid
EPS growth (1y)
44.09%
Strong
EPS CAGR (5y)
24.23%
Exceptional
EPS revisions (3 months)
-32.99%
Sharply revised down
Valuation
10.0/10P/E 2.3x, forward P/E 4.4x, PEG 0.09. The multiple sits in the 11th percentile of its own 5-year history.
P/E (TTM)
2.3x
Cheap
Sector 13.7x|S&P 23.6x
Forward P/E (adjusted)
4.4x
Cheap
EV / EBITDA
—
Sector 79.1x|S&P 15.5x
PEG
0.09
Growth unpriced
Sector 0.96|S&P 0.91
P/E vs its own 5-year history
among the 11% lowest valuations
Far cheaper than usual
Market cap
879Md CNY
Not scored for a bank or an insurer: its solidity is measured by regulatory capital ratios, which we do not collect.
Net debt / EBITDA
-22.5x
Gearing (net debt / equity)
15.50%
Cash
—
Net debt
111Md CNY
Equity
717Md CNY
Closed daily candles, 2 years
Last close on November 11, 2026: 24.38 HKD
- MM2024.22
- MM5026.92
- MM20028.62
- RSI 1442.2
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
-2.09%
200-day average slope, 3 months
-0.38%
50-day average slope, 1 month
-5.81%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
2.16 % per day
Volatility change
-8.75%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 3.01 (5) | 3.13 (3) | 737 631 (1) | — | 103 659 (2) |
| 2027 | 4.45 (14) | 4.61 (9) | 644 047 (3) | — | 128 232 (13) |
Amounts in millions of CNY, EPS in CNY per share. In brackets, the number of analysts. Consensus as of November 10, 2026.
Same sub-industry: 81 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2628 | 7.3 | 8.8 | 132Md USD | 2.3x | 41.3 % | 11.9 % | — | — | — | -10.9 % | ||
| 2 | MET | 7.2 | 7.2 | 64.7Md USD | 13.4x | 6.2 % | 19.4 % | — | — | — | 33.0 % | ||
| 3 | 601318 | 6.7 | 7.3 | 136Md USD | — | — | 6.5 % | — | — | — | -10.3 % | ||
| 4 | 1299 | 6.2 | 5.7 | 105Md USD | 13.3x | 23.2 % | 10.0 % | — | — | — | -4.8 % | ||
| 5 | LICI | 6.2 | 6.1 | 53.9Md USD | 8.2x | 6.1 % | 9.8 % | — | — | — | -10.3 % | ||
| 6 | MFC | 5.8 | 4.7 | 72.8Md USD | 18.1x | 10.3 % | -31.3 % | — | — | — | 35.3 % | ||
| 7 | GWO | 5.7 | 4.8 | 59.1Md USD | 19.6x | 11.4 % | -67.1 % | — | — | — | 59.3 % | ||
| 8 | 2881 | 5.5 | 4.7 | 65.1Md USD | 13.7x | 18.1 % | -2.8 % | — | — | — | 73.8 % | ||
| 9 | AFL | 4.4 | 3.8 | 62.9Md USD | 18.5x | 21.2 % | -31.0 % | — | — | — | 11.4 % |
